Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Dutasteride and finasteride affect different cell types differently.

The new finasteride delivery system using chitosan-based nanoniosomes shows promise for prostate cancer prevention.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Raman spectroscopy can identify finasteride polymorphs in tablets.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Strontium ranelate is no longer available for treatment.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Policosanol biorefining shows promise for heart health, needing better academic-industrial collaboration.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

The new delivery system improved hair growth in alopecia treatment.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

The woman had a genetic condition causing high cortisol and androgen levels, treatable with dexamethasone.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Computational methods help design drugs targeting prostate cancer proteins.

The AMHR2-482A>G gene change is linked to higher PCOS risk.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Taking the same medication under different brand names caused harmful side effects.

Women also use 5α-reductase inhibitors, and their effects differ from men.